Company / FCF Margin
Verrica Pharmaceuticals Inc. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-805.6%
FY2025
5-year range
-805.6% / -209.8%
FY2021-FY2025
Trend
-6.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -209.8% to -805.6% over the past 2 years.
Based on SEC 10-K filings.
-805.6% in FY2025 with a 3-year CAGR of -568.4%.
Declined from -209.8% to -805.6% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -568.4pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin decreased 6.0% year-over-year.
- Peak fcf margin was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -3.86 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -805.6% | -6.0% |
| FY2024 | -759.9% | -262.2% |
| FY2023 | -209.8% | +11.5% |
| FY2022 | -237.2% | +10.1% |
| FY2021 | -264.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026